Laboratory Testing

Laboratory testing, whether by public or private organisations, is a key element of the diagnostics sector. In the US the testing laboratories industry includes about 5,000 companies with combined annual revenue of about $12 billion.

The publications listed under Research and Markets’ Laboratory Testing category cover a wide range of key topics, including clinical trials of drugs and therapies; clinical labs around the world; the latest laboratory technologies (microscopes, cytometers, centrifuges, incubators, immunoassay instruments, etc.); as well as e-learning modules on laboratory testing techniques and safety requirements. They provide much-needed insight for potential laboratory testing service providers, investors, market entrants and healthcare/pharmaceutical professionals in general.

Examples of companies featured include National Technical Systems, Wyle Laboratories, Underwriters Laboratories, and the US operations of Bureau Veritas and SGS. Show Less ... more

• Laboratory Glassware (UK)

  EURO€ 416.00USD$ 541.00GBP£ 350.00AUD$ 529.00JPY¥ 53,436.00SEK 3 554,00CHF 510.00CAD$ 551.00 Plimsoll Publishing Ltd, May 2013 , Pages: 240
  Plimsoll Publishing’s UK Laboratory Glassware Analysis provides a detailed overview of the UK Laboratory Glassware market and delivers a comprehensive individual analysis on the top 70 companies, including...

• Scientific & Laboratory Equipment (UK)

  EURO€ 416.00USD$ 541.00GBP£ 350.00AUD$ 529.00JPY¥ 53,436.00SEK 3 554,00CHF 510.00CAD$ 551.00 Plimsoll Publishing Ltd, May 2013 , Pages: 1400
  Plimsoll Publishing’s UK Scientific & Laboratory Equipment Analysis provides a detailed overview of the UK Scientific & Laboratory Equipment market and delivers a comprehensive individual analysis on...

• Laboratories (UK)

  EURO€ 416.00USD$ 541.00GBP£ 350.00AUD$ 529.00JPY¥ 53,436.00SEK 3 554,00CHF 510.00CAD$ 551.00 Plimsoll Publishing Ltd, May 2013 , Pages: 2100
  Plimsoll Publishing’s UK Laboratories Analysis provides a detailed overview of the UK Laboratories market and delivers a comprehensive individual analysis on the top 1000 companies, including PFIZER...

• Laboratories (Spain)

  EURO€ 618.00USD$ 804.00GBP£ 520.00AUD$ 786.00JPY¥ 79,391.00SEK 5 280,00CHF 758.00CAD$ 819.00 Plimsoll Publishing Ltd, May 2013 , Pages: 860
  Plimsoll Publishing’s LABORATORIES (Spain) Analysis provides a detailed overview of the LABORATORIES (Spain) market and delivers a comprehensive individual analysis on the top 390 companies, including...

• Testing Laboratories World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2032
  TESTING LABORATORIES WORLD REPORT The Testing Laboratories World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series:...

• Testing Laboratory Lines World Report

  EURO€ 2,318.00USD$ 3,015.00GBP£ 1,950.00AUD$ 2,949.00JPY¥ 297,715.00SEK 19 798,00CHF 2'842.00CAD$ 3,073.00 PureData, May 2013 , Pages: 2092
  TESTING LABORATORY LINES WORLD REPORT The Testing Laboratory Lines World Report gives Market Consumption / Products / Services for over 200 countries by 6 to 10-Digit NAICS Product Codes by 3 Time...

• Medical & Diagnostic Laboratories

  EURO€ 99.00USD$ 129.00GBP£ 83.00AUD$ 126.00JPY¥ 12,737.00SEK 847,00CHF 122.00CAD$ 131.00 First Research, Apr 2013 , Pages: 10
  First Research is the leading industry intelligence company that helps sales teams perform faster and smarter, open doors, and close more deals. First Research performs the heavy lifting" by synthesizing...

• Testing Laboratories

  EURO€ 99.00USD$ 129.00GBP£ 83.00AUD$ 126.00JPY¥ 12,737.00SEK 847,00CHF 122.00CAD$ 131.00 First Research, Mar 2013 , Pages: 10
  First Research is the leading industry intelligence company that helps sales teams perform faster and smarter, open doors, and close more deals. First Research performs the heavy lifting" by synthesizing...

• Printing Inks - Global Strategic Business Report

  EURO€ 4,381.00USD$ 4,950.00GBP£ 2,920.00AUD$ 6,845.00JPY¥ 593,598.00SEK 38 940,00CHF 6'519.00CAD$ 6,349.00 Global Industry Analysts, Inc, Mar 2013 , Pages: 858
  This report analyzes the worldwide markets for Printing Inks in US$ Million and Thousands of Tons by the following Product Segments: Lithographic Inks, Flexographic Inks, Gravure Inks, Letterpress Inks,...

• Nonclinical Study Contracting and Monitoring

  EURO€ 65.00USD$ 84.00GBP£ 55.00AUD$ 83.00JPY¥ 8,343.00SEK 555,00CHF 80.00CAD$ 86.00 Elsevier Science and Technology, Feb 2013 , Pages: 262
  Nonclinical Study Contracting and Monitoring: A Practical Guide offers a systematic and straightforward handbook for obtaining high quality preclinical Good Laboratory Practice (GLP) studies. This book...

• Global Flow Cytometry Market 2012-2016

  EURO€ 1,537.00USD$ 2,000.00GBP£ 1,293.00AUD$ 1,956.00JPY¥ 197,466.00SEK 13 132,00CHF 1'885.00CAD$ 2,038.00 Infiniti Research Limited, Feb 2013 , Pages: 40
  TechNavio's analysts forecast the Global Flow Cytometry market to grow at a CAGR of 10 82 percent over the period 2012-2016 One of the key factors contributing to this market growth is the increase...

• 2013 Japanese Hospital Microbiology Testing Market

  EURO€ 4,458.00USD$ 5,800.00GBP£ 3,751.00AUD$ 5,673.00JPY¥ 572,651.00SEK 38 082,00CHF 5'467.00CAD$ 5,910.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital microbiology testing market, including:  Major issues pertaining...

• 2013 Spanish Hospital Microbiology Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 880 pages, 73 tables, and presents a comprehensive analysis of the Spanish hospital microbiology testing market, including:  Major issues pertaining...

• 2013 UK Hospital Microbiology Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: - Major issues pertaining...

• 2013 US Hospital Microbiology Testing Market

  EURO€ 5,227.00USD$ 6,800.00GBP£ 4,397.00AUD$ 6,651.00JPY¥ 671,384.00SEK 44 648,00CHF 6'409.00CAD$ 6,929.00 Venture Planning Group (VPG), Jan 2013 , Pages: 997
  This new report from Venture Planning Group contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital microbiology testing market, including: Major issues pertaining to...

• 2013 French Hospital Microbiology Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital microbiology testing market, including:  Major issues pertaining...

• 2013 Italian Hospital Microbiology Testing Market

  EURO€ 3,421.00USD$ 4,450.00GBP£ 2,878.00AUD$ 4,352.00JPY¥ 439,362.00SEK 29 218,00CHF 4'194.00CAD$ 4,534.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian microbiology disease testing market, including:  Major issues pertaining...

• 2013 Japanese Hospital Hematology and Flow Cytometry Market

  EURO€ 3,728.00USD$ 4,850.00GBP£ 3,136.00AUD$ 4,744.00JPY¥ 478,855.00SEK 31 844,00CHF 4'571.00CAD$ 4,942.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the Japanese hospital hematology and flow cytometry markets, including:  Major issues...

• 2013 Spanish Hospital Hematology and Flow Cytometry Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 236 pages, 15 tables, and presents a comprehensive analysis of the Spanish hospital hematology and flow cytometry markets, including:  Major issues...

• 2013 UK Hospital Hematology and Flow Cytometry Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 235 pages, 15 tables, and presents a comprehensive analysis of the UK hospital hematology and flow cytometry markets, including:  Major issues...

• 2013 US Hospital Hematology and Flow Cytometry Market

  EURO€ 5,227.00USD$ 6,800.00GBP£ 4,397.00AUD$ 6,651.00JPY¥ 671,384.00SEK 44 648,00CHF 6'409.00CAD$ 6,929.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 248 pages, 15 tables, and presents a comprehensive analysis of the US hospital hematology and flow cytometry markets, including: Major issues pertaining...

• 2013 French Hospital Tumor Marker Testing Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including:  Major issues pertaining...

• 2013 French Hospital Hematology and Flow Cytometry Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 231 pages, 13 tables, and presents a comprehensive analysis of the French hospital hematology and flow cytometry markets, including:  Major issues...

• 2013 German Hospital Hematology and Flow Cytometry Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the German hospital hematology and flow cytometry markets, including:  Major issues...

• 2013 Italian Hospital Hematology and Flow Cytometry Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the Italian hospital hematology and flow cytometry markets, including:  Major issues...

• 2013 German Hospital Tumor Marker Testing Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 530 pages, 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including:   Major issues pertaining...

• 2013 Italian Hospital Tumor Marker Testing Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 525 pages, 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including:  Major issues pertaining...

• 2013 Japanese Hospital Tumor Marker Testing Market

  EURO€ 3,728.00USD$ 4,850.00GBP£ 3,136.00AUD$ 4,744.00JPY¥ 478,855.00SEK 31 844,00CHF 4'571.00CAD$ 4,942.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 537 pages, 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including:  Major issues pertaining...

• 2013 Spanish Hospital Tumor Marker Testing Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from  Venture Planning Group contains 521 pages, 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including:  Major issues pertaining...

• 2013 UK Hospital Tumor Marker Testing Market

  EURO€ 2,959.00USD$ 3,850.00GBP£ 2,490.00AUD$ 3,766.00JPY¥ 380,122.00SEK 25 279,00CHF 3'629.00CAD$ 3,923.00 Venture Planning Group (VPG), Jan 2013
  This new report from  Venture Planning Group contains 527 pages, 37 tables, and presents a comprehensive analysis of the UK hospital tumor marker testing market, including:  Major issues pertaining...

• 2013 US Hospital Tumor Marker Testing Market

  EURO€ 4,996.00USD$ 6,500.00GBP£ 4,203.00AUD$ 6,357.00JPY¥ 641,764.00SEK 42 678,00CHF 6'126.00CAD$ 6,623.00 Venture Planning Group (VPG), Jan 2013
  This new report from Venture Planning Group contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: - Major issues pertaining...

• Laboratory Testing Services in the US

  EURO€ 784.00USD$ 1,020.00GBP£ 660.00AUD$ 998.00JPY¥ 100,708.00SEK 6 697,00CHF 961.00CAD$ 1,039.00 IBISWorld, Dec 2012 , Pages: 35
  High scores: Stringent standards across many companies will boost laboratory testing Laboratory Testing Services in the US Standing the test of time The industry remained strong during the recession...

• 2013 Projected Global Laboratory Products Budgets

  EURO€ 7,687.00USD$ 10,000.00GBP£ 6,467.00AUD$ 9,781.00JPY¥ 987,330.00SEK 65 658,00CHF 9'425.00CAD$ 10,190.00 Frost & Sullivan, Dec 2012 , Pages: 106
  Brands Named, Purchasing Trends Identified This survey of 170 laboratory managers and researchers investigates budgets for these product categories: instruments, equipment, chemicals, life science reagents...

• 2013 Worldwide Medical Laboratories Industry-Industry & Market Report

  EURO€ 191.00USD$ 249.00GBP£ 161.00AUD$ 244.00JPY¥ 24,585.00SEK 1 635,00CHF 235.00CAD$ 254.00 Barnes Reports, Dec 2012 , Pages: 104
  The 2013 Worldwide Medical Laboratories Industry-Industry & Market Report, published annually , contains timely and accurate industry statistics, forecasts and demographics The report features 2013...

• Arcadia Resources Inc.,(KADR) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Arcadia Resources Inc. (KADR), plus vital industry benchmarks and extensive operating ratios, along with an...

• AtCor Medical Holdings Limited,(AMDHF) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AtCor Medical Holdings Limited (AMDHF), plus vital industry benchmarks and extensive operating ratios, along...

• Baxter International Inc,(BAX) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Baxter International Inc (BAX), plus vital industry benchmarks and extensive operating ratios, along with...

• Atrion Corporation,(ATRI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Atrion Corporation (ATRI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Avitar, Inc.,(AVTI) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 47
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Avitar, Inc. (AVTI), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• ArQule Inc,(ARQL) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ArQule Inc (ARQL), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• ArthroCare Corp,(ARTC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for ArthroCare Corp (ARTC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Assurant Inc,(AIZ) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Assurant Inc (AIZ), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• AstraZeneca plc,(AZN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AstraZeneca plc (AZN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Athenahealth Inc,(ATHN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Athenahealth Inc (ATHN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Banyan Corporation,(BNYN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Banyan Corporation (BNYN), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• Astellas Pharma Inc,(ALPMY) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Astellas Pharma Inc (ALPMY), plus vital industry benchmarks and extensive operating ratios, along with an...

• AtriCure, Inc.,(ATRC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AtriCure, Inc. (ATRC), plus vital industry benchmarks and extensive operating ratios, along with an analysis...

• AxoGen Inc,(AXGN) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for AxoGen Inc (AXGN), plus vital industry benchmarks and extensive operating ratios, along with an analysis of...

• Arrhythmia Research Technology,(HRT) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 52
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Arrhythmia Research Technology (HRT), plus vital industry benchmarks and extensive operating ratios, along...

• Assisted Living Concepts Inc.,(ALC) Profile and Financials, plus Health Care Industry Trends Analysis, Operating Ratio and Financial Averages

  EURO€ 76.00USD$ 99.00GBP£ 64.00AUD$ 97.00JPY¥ 9,775.00SEK 650,00CHF 93.00CAD$ 101.00 Plunkett Research Ltd, Dec 2012 , Pages: 51
  Why You Should Buy This Report: A value-packed package of corporate financial analysis, for Assisted Living Concepts Inc. (ALC), plus vital industry benchmarks and extensive operating ratios, along...